UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended June 30, 2008

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the transition period from              to             .

Commission File Numbers	333-132495
	333-132495-53

Team Finance LLC

(Exact name of registrant as specified in its charter)

Delaware	20-3818106
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

Health Finance Corporation

(Exact name of registrant as specified in its charter)

Delaware	20-3818041
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

1900 Winston Road

Suite 300

Knoxville, Tennessee 37919

(865) 693-1000

(Address, zip code, and telephone number, including area code, of registrant’s principal executive office.)

Indicate by check mark whether the registrants (1) have filed all reports required to be filed by Section 13 and 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.

Yes  x    No  ¨

Indicate by check mark whether the registrants are large accelerated filers, accelerated filers, non-accelerated filers or smaller reporting companies. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  ¨		Accelerated filer  ¨
Non-accelerated filer  x	(Do not check if a smaller reporting company)	Smaller reporting company  ¨

Indicate by check mark whether the registrants are a shell company (as defined in Rule 12b-2 of the Exchange Act)

Yes  ¨    No  x

As of August 11, 2008, there were outstanding 1,000 Class A Units of Team Finance LLC and 100 shares of Common Stock, with a par value of $.01 of Health Finance Corporation.

FORWARD LOOKING STATEMENTS

Statements made in this Form 10-Q that are not historical facts and that reflect the current view of Team Finance LLC and Team Health, Inc. (collectively, the “Company”) about future events and financial performance are hereby identified as “forward looking statements.” Some of these statements can be identified by terms and phrases such as “anticipate,” “believe,” “intend,” “estimate,” “expect,” “continue,” “could,” “should”, “may,” “plan,” “project,” “predict” and similar expressions and include references to assumptions that we believe are reasonable and relate to our future prospects, developments and business strategies. The Company cautions readers of this Form 10-Q that such “forward looking statements”, including without limitation, those relating to the Company’s future business prospects, revenue, working capital, professional liability expense, liquidity, capital needs, interest costs and income, wherever they occur in this Form 10-Q or in other statements attributable to the Company, are necessarily estimates reflecting the judgment of the Company’s senior management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the “forward looking statements”. Factors that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements, include, but are not limited to:

• the effect and interpretation of current or future government regulation of the healthcare industry, and our ability to comply with these regulations;

• our exposure to professional liability lawsuits and governmental agency investigations;

• the adequacy of our insurance coverage and insurance reserves;

• our reliance on third-party payers;

• the general level of emergency department patient volumes at our clients’ facilities;

• our ability to enter into and retain contracts with hospitals, military treatment facilities and other healthcare facilities on attractive terms;

• changes in rates or methods of government payments for our services;

• our ability to successfully integrate strategic acquisitions;

• the control of our company by our sponsor may be in conflict with our interests;

• our future capital needs and ability to obtain future financing;

• our ability to carry out our business strategy;

• our ability to continue to recruit and retain qualified healthcare professionals and our ability to attract and retain operational personnel;

• competition in our market;

• our ability to maintain or implement complex information systems;

• our substantial indebtedness;

• our ability to generate cash flow to service our debt obligations;

• certain covenants in our debt documents;

• general economic conditions; and

• other factors detailed from time to time in the Company’s filings with the Securities and Exchange Commission, including filings on Forms 10-Q and 10-K.

The Company disclaims any intent or obligation to update “forward looking statements” made in this Form 10-Q to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time.

2

TEAM FINANCE LLC

QUARTERLY REPORT FOR THE THREE MONTHS

ENDED JUNE 30, 2008

		Page
Part 1. Financial Information
Item 1.	Financial Statements (Unaudited)
	Consolidated Balance Sheets—June 30, 2008 and December 31, 2007	4
	Consolidated Statements of Operations—Three months ended June 30, 2008 and 2007	5
	Consolidated Statements of Operations—Six months ended June 30, 2008 and 2007	6
	Consolidated Statements of Cash Flows—Six months ended June 30, 2008 and 2007	7
	Notes to Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	35
Item 4T.	Controls and Procedures	36
Part 2. Other Information
Item 1.	Legal Proceedings	37
Item 1A.	Risk Factors	37
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	37
Item 3.	Defaults Upon Senior Securities	37
Item 4.	Submission of Matters to a Vote of Security Holders	37
Item 5.	Other Information	37
Item 6.	Exhibits	38
Signatures		39

3

PART 1. FINANCIAL INFORMATION

Item  1. Financial Statements

TEAM FINANCE LLC

CONSOLIDATED BALANCE SHEETS

	June 30, 2008			December 31, 2007
	(Unaudited)
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	37,069		$	30,290
Accounts receivable, less allowance for uncollectibles of $161,111 and $165,226 in 2008 and 2007, respectively		224,901			222,603
Prepaid expenses and other current assets		20,115			13,242
Receivables under insured programs		25,637			34,118
Total current assets		307,722			300,253
Investments of insurance subsidiary		85,975			76,057
Property and equipment, net		24,903			25,276
Other intangibles, net		36,587			27,247
Goodwill		158,898			158,898
Deferred income taxes		50,709			60,104
Receivables under insured programs		26,652			23,896
Other		36,876			27,442
	$	728,322		$	699,173
LIABILITIES AND MEMBERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable	$	11,394		$	12,177
Accrued compensation and physician payable		100,003			101,421
Other accrued liabilities		73,191			83,854
Income tax payable		6,748			985
Current maturities of long-term debt		4,250			4,250
Deferred income taxes		26,155			27,635
Total current liabilities		221,741			230,322
Long-term debt, less current maturities		625,125			627,250
Other non-current liabilities		176,981			166,136
Accumulated other comprehensive earnings		3,352			434
Members’ deficit		(298,877	)		(324,969	)
	$	728,322		$	699,173

See accompanying notes to financial statements.

4

TEAM FINANCE LLC

CONSOLIDATED STATEMENTS OF OPERATIONS

	Three Months Ended June 30,
	2008		2007
	(Unaudited)
	(In thousands)
Net revenue	$	579,005	$	518,180
Provision for uncollectibles		243,519		215,373
Net revenue less provision for uncollectibles		335,486		302,807
Cost of services rendered
Professional service expenses		258,555		233,687
Professional liability costs		12,496		11,889
Gross profit		64,435		57,231
General and administrative expenses		30,831		26,997
Management fee and other expenses		899		885
Transaction costs		1,785		—
Depreciation and amortization		4,125		3,597
Interest expense, net		10,953		13,322
Earnings from continuing operations before income taxes		15,842		12,430
Provision for income taxes		6,198		4,727
Earnings from continuing operations		9,644		7,703
Loss from discontinued operations less applicable benefit from income taxes of $67		—		(110	)
Net earnings	$	9,644	$	7,593

See accompanying notes to financial statements.

5

TEAM FINANCE LLC

CONSOLIDATED STATEMENTS OF OPERATIONS

	Six Months Ended June 30,
	2008		2007
	(Unaudited)
	(In thousands)
Net revenue	$	1,138,026	$	1,004,132
Provision for uncollectibles		472,521		400,224
Net revenue less provision for uncollectibles		665,505		603,908
Cost of services rendered
Professional service expenses		513,792		462,011
Professional liability costs		12,550		6,214
Gross profit		139,163		135,683
General and administrative expenses		58,959		54,816
Management fee and other expenses		1,786		1,818
Transaction costs		1,785		—
Depreciation and amortization		8,006		7,087
Interest expense, net		23,595		27,792
Earnings from continuing operations before income taxes		45,032		44,170
Provision for income taxes		17,900		17,200
Earnings from continuing operations		27,132		26,970
Loss from discontinued operations less applicable benefit from income taxes of $217		—		(346	)
Net earnings	$	27,132	$	26,624

See accompanying notes to financial statements.

6

TEAM FINANCE LLC

CONSOLIDATED STATEMENTS OF CASH FLOWS

	Six Months Ended June 30,
	2008			2007
	(Unaudited)
	(In thousands)
Operating Activities
Net earnings	$	27,132		$	26,624
Adjustments to reconcile net earnings:
Depreciation and amortization		8,006			7,113
Amortization of deferred financing costs		1,041			1,091
Employee equity based compensation expense		276			280
Provision for uncollectibles		472,521			400,224
Deferred income taxes		6,044			11,428
Loss on disposal of equipment		36			67
Equity in joint venture income		(580	)		(835	)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable		(474,819	)		(402,795	)
Prepaids and other assets		(11,966	)		(13,460	)
Income tax accounts		5,635			2,548
Accounts payable		(667	)		(4,392	)
Accrued compensation and physician payable		(1,405	)		5,095
Other accrued liabilities		(1,800	)		1,316
Professional liability reserves		2,777			(5,079	)
Net cash provided by operating activities		32,231			29,225
Investing Activities
Purchases of property and equipment		(4,512	)		(8,053	)
Cash paid for acquisitions, net		(7,513	)		(1,094	)
Net purchases of investments by insurance subsidiary		(9,986	)		(9,374	)
Other investing activities		—			125
Net cash used in investing activities		(22,011	)		(18,396	)
Financing Activities
Payments on notes payable		(2,125	)		(2,125	)
Proceeds from revolving credit facility		—			69,500
Payments on revolving credit facility		—			(76,300	)
Payments of deferred financing costs		—			(500	)
Redemption of common units		(1,316	)		(797	)
Proceeds from sales of common units		—			50
Net cash used in financing activities		(3,441	)		(10,172	)
Net increase in cash		6,779			657
Cash and cash equivalents, beginning of period		30,290			3,999
Cash and cash equivalents, end of period	$	37,069		$	4,656
Interest paid	$	25,914		$	29,176
Taxes paid	$	6,320		$	1,280

See accompanying notes to financial statements.

7

TEAM FINANCE LLC

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Organization and Basis of Presentation

On November 23, 2005, affiliates of The Blackstone Group (“Blackstone”), a private equity firm, by way of merger with Team Health Holdings LLC (“Holdings”), acquired a 91.1% interest in Holdings (the “Recapitalization Merger”). Holdings became the parent corporation of Team Finance LLC (“Team Finance”). Also pursuant to the Merger Agreement dated October 11, 2005, Team MergerSub Inc., a Tennessee Corporation and wholly-owned subsidiary of Team Finance merged with and into Team Health, Inc. (“Team Health”) (the “Reorganization Merger”). References and information noted as being those of the “Company”, “we” or “our” relate to both Team Health and Team Finance. The remaining ownership in Holdings is held by members of management of the Company.

The accompanying unaudited consolidated financial statements include the accounts of Team Health and its wholly owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States for interim financial reporting and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States for complete financial statements.

In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments (consisting of normal recurring items) necessary for a fair presentation of results for the interim periods presented. The results of operations for any interim period are not necessarily indicative of results for the full year. The consolidated balance sheet of the Company at December 31, 2007 has been derived from the audited financial statements at that date, but does not include all of the information and disclosures required by accounting principles generally accepted in the United States for complete financial statements. These financial statements and footnote disclosures should be read in conjunction with the December 31, 2007 audited consolidated financial statements and the notes thereto included in the Company’s Form 10-K filed with the Securities and Exchange Commission on March 11, 2008.

The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements and notes. Actual results could differ from those estimates.

Note 2. New Accounting Standards

In March 2008, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 161, “Disclosures about Derivative Instruments and Hedging Activities—An Amendment of SFAS No. 133” (“SFAS 161”). SFAS 161 seeks to improve financial reporting for derivative instruments and hedging activities by requiring enhanced disclosures regarding the impact on financial position, financial performance, and cash flows. To achieve this increased transparency, SFAS 161 requires (1) the disclosure of the fair value of derivative instruments and gains and losses in a tabular format; (2) the disclosure of derivative features that are credit risk-related; and (3) cross-referencing within the footnotes. SFAS 161 is effective for the Company on January 1, 2009. The Company is in the process of evaluating the new disclosure requirements under SFAS 161.

In December 2007, the FASB issued SFAS No. 141 (Revised 2007), “Business Combinations” (“SFAS 141R”). SFAS 141R continues to require the purchase method of accounting to be applied to all business combinations, but it significantly changes the accounting for certain aspects of business combinations. Under SFAS 141R, an acquiring entity will be required to recognize all the assets acquired and liabilities assumed in a transaction at the acquisition-date fair value with limited exceptions. SFAS 141R will change the accounting

8

treatment for certain specific acquisition related items including: (1) expensing acquisition related costs as incurred; (2) valuing noncontrolling interests at fair value at the acquisition date; and (3) recognizing contingent consideration arrangements on the acquisition date at fair value. SFAS 141R also includes a substantial number of new disclosure requirements. SFAS 141R is to be applied prospectively to business combinations for which the acquisition date is on or after January 1, 2009. The Company expects SFAS 141R will have an impact on its accounting for future business combinations once adopted but the effect is dependent upon the acquisitions that are made in such periods.

In December 2007, the FASB released SFAS No. 160, “Noncontrolling Interests in Consolidated Financial Statements—an amendment of ARB No. 51” (“SFAS 160”). SFAS 160 is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2008, which for the Company is the year ending December 31, 2009 and the interim periods within that fiscal year. The objective of SFAS 160 is to improve the relevance, comparability, and transparency of the financial information that a reporting entity provides in its consolidated financial statements. SFAS 160 currently does not impact the Company as it has full controlling interest of all of its subsidiaries.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities” (“SFAS 159”). SFAS 159 allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (“fair value option”). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, SFAS 159 specifies that unrealized gains and losses for that instrument be reported in earnings at each subsequent reporting date. SFAS 159 was effective for the Company on January 1, 2008. The implementation of SFAS 159 did not have an impact on the Company’s results of operations, financial position or cash flows as the Company did not elect to measure any eligible items at fair value other than instruments such as investments or interest rate swaps that are currently required to be measured at fair value.

Note 3. Discontinued Operations

In January 2007, the Company completed a strategic review of Team Health Anesthesiology Management Services (“THAMS”), and based upon the review, concluded that the existing business model of providing management services to independent physician groups was not a viable long term strategy and could not consistently meet internal growth targets. As a result of this review, the Company elected to exit this non-core business line. The final phase of this business line disposal was completed in 2007 with no continuing operations in 2008, therefore, in accordance with the provisions of SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets”, the operating results of THAMS are presented in the accompanying consolidated statements of operations as a discontinued operation for all applicable periods presented.

The financial results of THAMS included in discontinued operations, are as follows (in thousands):

	Three Months Ended June 30,					Six Months Ended June 30,
	2008		2007			2008		2007
Net revenue	$	—	$	765		$	—	$	2,319
Total cost of services		—		69			—		409
Gross profit		—		696			—		1,910
Loss before income taxes		—		(177	)		—		(563	)
Benefit from income taxes		—		67			—		217
Loss from discontinued operations	$	—	$	(110	)	$	—	$	(346	)

The loss from discontinued operations in the three and six months ended June 30, 2007 include approximately $0.2 million and $0.9 million, respectively, of severance and other exit costs related to the disposal of this business unit.

9

For the three and six months ended June 30, 2008, THAMS had no operating use of cash and for the three and six months ended June 30, 2007 had a use of cash of $0.8 million and $0.9 million, respectively.

Note 4. Acquisition and Transaction Costs

Effective June 1, 2008, the Company completed the acquisition of certain assets and related business operations of an emergency medicine staffing business located in New Jersey. An officer of an affiliated corporation of the Company held an ownership interest in the selling party. The purchase price for the acquired business was $7.5 million which was paid in cash on the date of the closing. In addition, the Company may have to pay up to $6.7 million in deferred payments if future financial targets are achieved and certain contract terms are modified. In connection with the transaction the Company has recorded a $12.6 million contract intangible, which is the estimated fair value of the assets acquired at the date of the acquisition. The excess of fair value of the assets acquired compared to the amount paid as of the acquisition date has been reflected as “estimated amount due seller” in accordance with SFAS No. 141, “Business Combinations”. Any contingent consideration payable in the future will be first applied to reduce the amount recorded as “estimated amount due seller”, and thereafter recorded to goodwill.

In accordance with the provisions of SFAS 141, “Business Combinations”, the Company recognized $1.8 million of expenses, in June 2008, related to advisory, legal, accounting, and other fees incurred in connection with a terminated transaction effort.

Note 5. Fair Value Measurements

In the first quarter of 2008, the Company adopted SFAS No. 157, “Fair Value Measurements,” (“SFAS 157”) for financial assets and liabilities. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements.

SFAS No. 157 prioritizes the inputs used in measuring fair value into the following hierarchy:

Level 1	Quoted prices (unadjusted) in active markets for identical assets or liabilities;
Level 2	Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable;
Level 3	Unobservable inputs in which little or no market activity exists, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing.

The following table provides information on those assets and liabilities the Company measures at fair value on a recurring basis (in thousands):

	Carrying Amount In Consolidated Balance Sheet June 30, 2008		Fair Value June 30, 2008		Fair Value Level 1		Fair Value Level 2		Fair Value Level 3
Investments of insurance subsidiary	$	85,975	$	85,975	$	85,975	$	—	$	—
Interest rate swap asset		4,858		4,858		—		4,858		—

The fair value of the Company’s investments of insurance subsidiary are based on quoted prices. The fair value of the Company’s interest rate swaps were determined by the Company’s counterparty using inputs that are available in the public swap markets for similarly termed instruments and then making adjustments for terms specific to the Company’s instruments. See Note 8 for more information regarding our interest rate swap agreements.

10

Note 6. Net Revenue

Net revenue for the three and six months ended June 30, 2008 and 2007, respectively, consisted of the following (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2008		2007		2008		2007
Fee for service revenue	$	462,391	$	410,321	$	907,994	$	789,532
Contract revenue		110,983		101,266		218,699		202,058
Other revenue		5,631		6,593		11,333		12,542
	$	579,005	$	518,180	$	1,138,026	$	1,004,132

Note 7. Other Intangible Assets

The following is a summary of intangible assets and related amortization as of June 30, 2008 and December 31, 2007 (in thousands):

	Gross Carrying Amount		Accumulated Amortization
As of June 30, 2008:
Contracts	$	52,633	$	16,114
Other		448		380
Total	$	53,081	$	16,494
As of December 31, 2007:
Contracts	$	40,020	$	12,864
Other		448		357
Total	$	40,468	$	13,221
Aggregate amortization expense:
For the six months ended June 30, 2008	$	3,273
Estimated amortization expense:
For the remainder of the year ended December 31, 2008	$	4,149
For the year ended December 31, 2009		8,105
For the year ended December 31, 2010		7,674
For the year ended December 31, 2011		5,955
For the year ended December 31, 2012		5,523

Note 8. Long-Term Debt

Long-term debt as of June 30, 2008 consisted of the following (in thousands):

Term Loan Facilities	$	414,375
11.25% Senior Subordinated Notes		215,000
Revolving line of credit		—
		629,375
Less current portion		(4,250	)
	$	625,125

11

The interest rate for any revolving credit facility borrowings is based on a grid which is based on the consolidated ratio of total funded debt to earnings before interest, taxes, depreciation and amortization, all as set forth in the credit agreement. As of June 30, 2008, the interest rate for borrowings under the revolving credit facility was equal to the euro dollar rate plus 2.25% or the agent bank’s base rate plus 1.25%. In addition, the Company pays a commitment fee for the revolving credit facility which is equal to 0.5% of the commitment at June 30, 2008.

The interest rate at June 30, 2008 was 4.70% for amounts outstanding under the term loan facility. Effective April 5, 2007, the Company amended its senior credit agreement. The amendment reduced the interest rate on any term loans outstanding equal to the euro dollar rate plus 2.0% or the agent bank’s base rate plus 1.0%. Previously, the interest rate on term loan borrowings was equal to the euro dollar rate plus 2.50% or the agent bank’s base rate plus 1.50%. The Company is subject to an increase in the term loan interest rate in the amount of 0.25% in the event of a downgrade in the corporate family rating of the Company by either Moody’s or Standard and Poor’s rating agencies. Other significant terms and conditions of the credit agreement, including the maturity date of November 23, 2012, did not change under the amendment.

During the six months ended June 30, 2008, the Company entered into three separate forward interest rate swap agreements. The objective of the agreements is to eliminate the variability of the cash flows in interest payments for $200.0 million of the variable-rate term loan for a three-year period. The agreements are contracts to exchange, on a quarterly basis, floating interest rate payments based on the Eurocurrency rate, for fixed interest payments over the life of the agreements. The Company has determined the interest rate swaps are highly effective and qualify for hedge accounting, therefore at June 30, 2008, the Company has recorded the increase in fair value of the interest rate swaps, net of tax, of approximately $3.0 million as a component of other comprehensive earnings.

These agreements expose the Company to credit losses in the event of non-performance by the counterparty to the financial instruments. The counterparty is a creditworthy financial institution and the Company believes the counterparty will be able to fully satisfy its obligations under the contracts.

No borrowings under the $125.0 million revolving credit facility were outstanding as of June 30, 2008, and the Company had $7.2 million of standby letters of credit outstanding against the revolving credit facility commitment.

The Company issued on November 23, 2005, 11.25% Senior Subordinated Notes (the “Notes”) in the amount of $215.0 million due December 1, 2013. The Notes are subordinated in right of payment to all senior debt of the Company and are senior in right of payment to all existing and future subordinated indebtedness of the Company. Interest on the Notes accrues at the rate of 11.25% per annum, payable semi-annually in arrears on June 1 and December 1 of each year. Beginning on December 1, 2009, the Company may redeem some or all of the Notes at any time at various redemption prices.

The Notes are guaranteed jointly and severally on a full and unconditional basis by all of the Company’s domestic wholly-owned operating subsidiaries (the “Subsidiary Guarantors”) as required by the Indenture Agreement.

Both the 11.25% Notes and the current term loan facility contain both affirmative and negative covenants, including limitations on the Company’s ability to incur additional indebtedness, sell material assets, retire, redeem or otherwise reacquire its capital stock, acquire the capital stock or assets of another business, pay dividends, and require the Company to comply with certain coverage and leverage ratios.

12

Aggregate annual maturities of long-term debt as of June 30, 2008 are as follows (in thousands):

2008	$	4,250
2009		4,250
2010		4,250
2011		4,250
2012		397,375
Thereafter		215,000

Note 9. Professional Liability Insurance

The Company’s professional liability loss reserves consist of the following (in thousands):

	June 30, 2008		December 31, 2007
Estimated losses under self-insured programs	$	165,681	$	162,904
Estimated losses under commercial insurance programs		52,289		58,014
		217,970		220,918
Less estimated payable within one year		57,793		67,666
	$	160,177	$	153,252

The Company provides for its estimated professional liability losses through a combination of self-insurance and commercial insurance programs. During the period March 12, 1999 through March 11, 2003, the primary source of the Company’s coverage for such risks was a professional liability insurance policy provided through one insurance carrier. The commercial insurance carrier policy initially included an insured loss limit of $130.0 million. In April 2006, the Company amended the policy with its commercial insurance carrier to provide for an increase in the aggregate limit of coverage based upon certain premium funding levels. As of June 30, 2008, the insured loss limit under the policy was $150.8 million. Losses in excess of the limit of coverage remain as a self-insured obligation of the Company. Beginning March 12, 2003, professional liability loss risks are principally being provided for through self-insurance with a portion of such risks (“claims-made” basis) transferred to and funded into a captive insurance company. The accounts of the captive insurance company are fully consolidated with those of the other operations of the Company in the accompanying consolidated financial statements.

The self-insurance components of our risk management program include reserves for future claims incurred but not reported. The Company’s provisions for losses under its self-insurance components are estimated using the results of periodic actuarial studies performed by an independent actuarial firm. Such actuarial studies include numerous underlying estimates and assumptions, including assumptions as to future claim losses, the severity and frequency of such projected losses, loss development factors and others. The Company’s provisions for losses under its self-insured components are subject to subsequent adjustment should future actuarial projected results for such periods indicate projected losses greater or less than previously projected. The Company’s estimated loss reserves under such programs are discounted at 3.6%.

The Company’s most recent actuarial valuation was completed in April 2008. As a result of such actuarial valuation, the Company realized a reduction in its provision for professional liability losses of $13.8 million in the six months ended June 30, 2008, related to its reserves for losses in prior years. The Company had previously realized a $19.6 million reduction in its professional liability loss liability in the six months ended June 30, 2007, resulting from an actuarial study completed in April 2007.

13

Note 10. Share-based Compensation

In November 2005, the Company adopted the 2005 Unit Plan. A total of 400,000 Class B Common Units and 600,000 Class C Common Units are authorized for issuance to executives and other key employees under the 2005 Unit Plan. As of June 30, 2008, there were 320,451 restricted Class B Common Units and 448,631 Class C Common Units outstanding. The outstanding units vest ratably over five years and the Company is recognizing the related compensation expense over the five year period. Compensation expense for the employee equity based awards granted is based on the grant date fair value in accordance with the provisions of SFAS No. 123(R). For the six months ended June 30, 2008 and 2007, the Company recognized $0.3 million of employee equity based compensation expense. As of June 30, 2008, there was approximately $2.0 million of unrecognized compensation expense related to nonvested restricted unit awards, which will be recognized over the remaining requisite service period. Forfeitures of employee equity based awards have been historically immaterial to the Company.

Note 11. Contingencies

Litigation

We are currently a party to various legal proceedings. While we currently believe that the ultimate outcome of such proceedings, individually and in the aggregate, will not have a material adverse effect on our financial position or overall trends in results of operations, litigation is subject to inherent uncertainties. If an unfavorable ruling were to occur, there exists the possibility of a material adverse impact on our net earnings in the period in which a ruling occurs. The estimate of the potential impact from such legal proceedings on our financial position or overall results of operations could change in the future.

Healthcare Regulatory Matters

Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. Compliance with such laws and regulations can be subject to future governmental review and interpretation as well as significant regulatory action. From time to time, governmental regulatory agencies will conduct inquiries and audits of the Company’s practices. It is the Company’s current practice and future intent to cooperate fully with such inquiries.

In addition to laws and regulations governing the Medicare and Medicaid programs, there are a number of federal and state laws and regulations governing such matters as the corporate practice of medicine and fee splitting arrangements, anti-kickback statutes, physician self-referral laws, false or fraudulent claims filing and patient privacy requirements. The failure to comply with any of such laws or regulations could have an adverse impact on our operations and financial results. It is management’s belief that the Company is in substantial compliance in all material respects with such laws and regulations.

Acquisition Payments

As of June 30, 2008, the Company may have to pay up to $18.5 million in future contingent payments as additional consideration for acquisitions made prior to June 30, 2008. These payments will be made and recorded as additional purchase price or will reduce existing liabilities should the acquired operations achieve the financial targets or certain contract terms are modified as agreed to in the respective acquisition agreements. During the six months ended June 30, 2008, the Company made no payments related to previous acquisitions and made $1.1 million in the same period of 2007.

14

Note 12. Comprehensive Earnings

The components of comprehensive earnings, net of related taxes, are as follows (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2008			2007			2008			2007
Net earnings	$	9,644		$	7,593		$	27,132		$	26,624
Net change in fair market value of investments		(358	)		(268	)		(45	)		(129	)
Net change in fair market value of interest rate swap		3,313			—			2,963			—
Comprehensive earnings	$	12,599		$	7,325		$	30,050		$	26,495

Note 13. Segment Reporting

After consideration of the discontinued operations of its anesthesia management services business (Note 3), the Company provides services through four operating segments which are aggregated into two reportable segments, Healthcare Services and Billing Services. The Healthcare Services segment, which is an aggregation of healthcare staffing, clinics and occupational health, provides comprehensive healthcare service programs to users and providers of healthcare services on a fee-for-service as well as a cost plus basis. The Billing Services segment provides a range of external billing, collection and consulting services on a fee basis to outside third-party customers.

Segment amounts disclosed are prior to any elimination entries made in consolidation, except in the case of net revenue, where intercompany charges have been eliminated. Certain expenses are not allocated to the segments. These unallocated expenses are corporate expenses, net interest expense, depreciation and amortization, transaction costs and income taxes. The Company evaluates segment performance based on profit and loss before the aforementioned expenses.

The following table presents financial information for each reportable segment. Depreciation, amortization, management fee and other expenses separately identified in the consolidated statements of operations are included as a reduction to the operating earnings of each segment in each period below (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2008			2007			2008			2007
Net Revenue less provision for uncollectibles:
Healthcare Services	$	332,446		$	299,767		$	659,473		$	597,768
Billing Services		3,040			3,040			6,032			6,140
	$	335,486		$	302,807		$	665,505		$	603,908
Operating earnings:
Healthcare Services	$	40,232		$	36,802		$	93,571		$	94,076
Billing Services		593			448			1,145			1,159
General Corporate		(12,245	)		(11,498	)		(24,304	)		(23,273	)
	$	28,580		$	25,752		$	70,412		$	71,962

15

Note 14. Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiary

The Company conducts substantially all of its business through its subsidiaries. The parent company is a holding company that conducts no operations and whose financial position, excluding its investments in its subsidiaries, is comprised of deferred financing costs and the Company’s debt. The Company’s domestic, wholly-owned subsidiaries jointly and severally guarantee the 11.25% Notes on an unsecured senior subordinated basis. The condensed consolidating financial information for the parent company, the issuers of the 11.25% Notes, and the subsidiary guarantors, the non-guarantor subsidiary, certain reclassifications and eliminations and the consolidated Company as of June 30, 2008 and December 31, 2007 and for the three and six months ended June 30, 2008 and 2007, are as follows:

Consolidated Balance Sheet

	As of June 30, 2008
	Parent and Guarantor Subsidiaries			Non-Guarantor Subsidiary		Reclassifications and Eliminations			Total Consolidated
	(in thousands)
Assets
Current assets:
Cash and cash equivalents	$	37,069		$	—	$	—		$	37,069
Accounts receivable, net		224,901			—		—			224,901
Prepaid expenses and other current assets		18,765			35,384		(34,034	)		20,115
Income tax receivables		—			681		(681	)		—
Receivables under insurance programs		25,637			—		—			25,637
Total current assets		306,372			36,065		(34,715	)		307,722
Investments of insurance subsidiary		—			85,975		—			85,975
Property and equipment, net		24,903			—		—			24,903
Other intangibles, net		36,587			—		—			36,587
Goodwill		158,898			—		—			158,898
Deferred income taxes		46,299			—		4,410			50,709
Receivables under insured programs		26,652			—		—			26,652
Investments in subsidiary		9,845			—		(9,845	)		—
Other		36,521			355		—			36,876
	$	646,077		$	122,395	$	(40,150	)	$	728,322
Liabilities and members’ equity (deficit)
Current liabilities:
Accounts payable	$	2,359		$	9,035	$	—		$	11,394
Accrued compensation and physician payable		100,003			—		—			100,003
Other accrued liabilities		40,968			61,847		(29,624	)		73,191
Income tax payable		7,429			—		(681	)		6,748
Current maturities of long-term debt		4,250			—		—			4,250
Deferred income taxes		26,155			—		—			26,155
Total current liabilities		181,164			70,882		(30,305	)		221,741
Long-term debt, less current maturities		625,125			—		—			625,125
Other non-current liabilities		135,313			41,668		—			176,981
Common stock		—			120		(120	)		—
Additional paid in capital		—			4,610		(4,610	)		—
Retained earnings		—			4,726		(4,726	)		—
Accumulated other comprehensive earnings		2,963			389		—			3,352
Members’ deficit		(298,488	)		—		(389	)		(298,877	)
	$	646,077		$	122,395	$	(40,150	)	$	728,322

16

Consolidated Balance Sheet

	As of December 31, 2007
	Parent and Guarantor Subsidiaries			Non-Guarantor Subsidiary		Reclassifications and Eliminations			Total Consolidated
	(in thousands)
Assets
Current assets:
Cash and cash equivalents	$	30,290		$	—	$	—		$	30,290
Accounts receivable, net		222,603			—		—			222,603
Prepaid expenses and other current assets		12,248			21,148		(20,154	)		13,242
Receivables under insured programs		34,118			—		—			34,118
Total current assets		299,259			21,148		(20,154	)		300,253
Investments of insurance subsidiary		—			76,057		—			76,057
Property and equipment, net		25,276			—		—			25,276
Other intangibles, net		27,247			—		—			27,247
Goodwill		158,898			—		—			158,898
Deferred income taxes		56,212			—		3,892			60,104
Receivables under insured programs		23,896			—		—			23,896
Investment in subsidiary		13,952			—		(13,952	)		—
Other		27,316			126		—			27,442
	$	632,056		$	97,331	$	(30,214	)	$	699,173
Liabilities and members’ equity (deficit)
Current liabilities:
Accounts payable	$	12,103		$	74	$	—		$	12,177
Accrued compensation and physician payable		101,421			—		—			101,421
Other accrued liabilities		50,272			49,844		(16,262	)		83,854
Income tax payable		661			324		—			985
Current maturities of long-term debt		4,250			—		—			4,250
Deferred income taxes		27,402			233		—			27,635
Total current liabilities		196,109			50,475		(16,262	)		230,322
Long-term debt, less current maturities		627,250			—		—			627,250
Other non-current liabilities		133,232			32,904		—			166,136
Common stock		—			120		(120	)		—
Additional paid in capital		—			4,610		(4,610	)		—
Retained earnings		—			8,788		(8,788	)		—
Accumulated other comprehensive earnings		—			434		—			434
Members’ deficit		(324,535	)		—		(434	)		(324,969	)
	$	632,056		$	97,331	$	(30,214	)	$	699,173

17

Consolidated Statement of Operations

	Three Months Ended June 30, 2008
	Parent and Guarantor Subsidiaries		Non-Guarantor Subsidiary			Reclassifications and Eliminations			Total Consolidated
	(in thousands)
Net revenue	$	579,005	$	9,198		$	(9,198	)	$	579,005
Provision for uncollectibles		243,519		—			—			243,519
Net revenue less provision for uncollectibles		335,486		9,198			(9,198	)		335,486
Cost of services rendered
Professional expenses		271,867		8,382			(9,198	)		271,051
Gross profit		63,619		816			—			64,435
General and administrative expenses		30,783		48			—			30,831
Management fee and other expenses		899		—			—			899
Transaction costs		1,785		—			—			1,785
Depreciation and amortization		4,125		—			—			4,125
Interest expense (income), net		11,745		(792	)		—			10,953
Earnings before income taxes		14,282		1,560			—			15,842
Provision for income taxes		5,652		546			—			6,198
Net earnings	$	8,630	$	1,014		$	—		$	9,644

Consolidated Statement of Operations

	Three Months Ended June 30, 2007
	Parent and Guarantor Subsidiaries			Non-Guarantor Subsidiary			Reclassifications and Eliminations			Total Consolidated
	(in thousands)
Net revenue	$	518,180		$	9,969		$	(9,969	)	$	518,180
Provision for uncollectibles		215,373			—			—			215,373
Net revenue less provision for uncollectibles		302,807			9,969			(9,969	)		302,807
Cost of services rendered
Professional expenses		247,391			8,154			(9,969	)		245,576
Gross profit		55,416			1,815			—			57,231
General and administrative expenses		26,962			35			—			26,997
Management fee and other expenses		885			—			—			885
Depreciation and amortization		3,597			—			—			3,597
Interest expense (income), net		14,168			(846	)		—			13,322
Earnings from continuing operations before income taxes		9,804			2,626			—			12,430
Provision for income taxes		3,808			919			—			4,727
Earnings from continuing operations		5,996			1,707			—			7,703
Loss from discontinued operations net of taxes		(110	)		—			—			(110	)
Net earnings	$	5,886		$	1,707		$	—		$	7,593

18

Consolidated Statement of Operations

	Six Months Ended June 30, 2008
	Parent and Guarantor Subsidiaries		Non-Guarantor Subsidiary			Reclassifications and Eliminations			Total Consolidated
	(in thousands)
Net revenue	$	1,138,026	$	18,956		$	(18,956	)	$	1,138,026
Provision for uncollectibles		472,521		—			—			472,521
Net revenue less provision for uncollectibles		665,505		18,956			(18,956	)		665,505
Cost of services rendered
Professional expenses		533,697		11,601			(18,956	)		526,342
Gross profit		131,808		7,355			—			139,163
General and administrative expenses		58,872		87			—			58,959
Management fee and other expenses		1,786		—			—			1,786
Transaction costs		1,785		—			—			1,785
Depreciation and amortization		8,006		—			—			8,006
Interest expense (income), net		25,461		(1,866	)		—			23,595
Earnings before income taxes		35,898		9,134			—			45,032
Provision for income taxes		14,703		3,197			—			17,900
Net earnings	$	21,195	$	5,937		$	—		$	27,132

Consolidated Statement of Operations

	Six Months Ended June 30, 2007
	Parent and Guarantor Subsidiaries			Non-Guarantor Subsidiary			Reclassifications and Eliminations			Total Consolidated
	(in thousands)
Net revenue	$	1,004,132		$	20,044		$	(20,044	)	$	1,004,132
Provision for uncollectibles		400,224			—			—			400,224
Net revenue less provision for uncollectibles		603,908			20,044			(20,044	)		603,908
Cost of services rendered
Professional expenses		485,156			3,113			(20,044	)		468,225
Gross profit		118,752			16,931			—			135,683
General and administrative expenses		54,676			140			—			54,816
Management fee and other expenses		1,818			—			—			1,818
Depreciation and amortization		7,087			—			—			7,087
Interest expense (income), net		29,278			(1,486	)		—			27,792
Earnings from continuing operations before income taxes		25,893			18,277			—			44,170
Provision for income taxes		10,803			6,397			—			17,200
Earnings from continuing operations		15,090			11,880			—			26,970
Loss from discontinued operations net of taxes		(346	)		—			—			(346	)
Net earnings	$	14,744		$	11,880		$	—		$	26,624

19

Consolidated Statement of Cash Flows

	Six Months Ended June 30, 2008
	Parent and Guarantor Subsidiaries			Non-Guarantor Subsidiary			Reclassifications and Eliminations		Total Consolidated
	(in thousands)
Operating activities
Net earnings	$	21,195		$	5,937		$	—	$	27,132
Adjustments to reconcile net earnings:
Depreciation and amortization		8,006			—			—		8,006
Amortization of deferred financing costs		1,041			—			—		1,041
Employee equity based compensation expense		276			—			—		276
Provision for uncollectibles		472,521			—			—		472,521
Deferred income taxes		6,771			(727	)		—		6,044
Loss on disposal of equipment		36			—			—		36
Equity in joint venture income		(580	)		—			—		(580	)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable		(474,819	)		—			—		(474,819	)
Prepaids and other assets		1,981			(13,947	)		—		(11,966	)
Income tax accounts		6,639			(1,004	)		—		5,635
Accounts payable		(646	)		(21	)		—		(667	)
Accrued compensation and physician payable		(1,405	)		—			—		(1,405	)
Other accrued liabilities		(15,194	)		13,394			—		(1,800	)
Professional liability reserves		(4,595	)		7,372			—		2,777
Net cash provided by operating activities		21,227			11,004			—		32,231
Investing activities
Purchases of property and equipment		(4,512	)		—			—		(4,512	)
Cash paid for acquisitions, net		(7,513	)		—			—		(7,513	)
Net purchases of investments by insurance subsidiary		—			(9,986	)		—		(9,986	)
Net cash used in investing activities		(12,025	)		(9,986	)		—		(22,011	)
Financing activities
Payments on notes payable		(2,125	)		—			—		(2,125	)
Redemption of common units		(1,316	)		—			—		(1,316	)
Net transfer from parent and parent’s subsidiaries		1,018			(1,018	)		—		—
Net cash used in financing activities		(2,423	)		(1,018	)		—		(3,441	)
Net increase in cash		6,779			—			—		6,779
Cash and cash equivalents, beginning of period		30,290			—			—		30,290
Cash and cash equivalents, end of period	$	37,069		$	—		$	—	$	37,069

20

Consolidated Statement of Cash Flows

	Six Months Ended June 30, 2007
	Parent and Guarantor Subsidiaries			Non-Guarantor Subsidiary			Reclassifications and Eliminations		Total Consolidated
	(in thousands)
Operating activities
Net earnings	$	14,744		$	11,880		$	—	$	26,624
Adjustments to reconcile net earnings:
Depreciation and amortization		7,113			—			—		7,113
Amortization of deferred financing costs		1,091			—			—		1,091
Employee based compensation expense		280			—			—		280
Provision for uncollectibles		400,224			—			—		400,224
Deferred income taxes		10,585			843			—		11,428
Loss on sale of equipment		67			—			—		67
Equity in joint venture income		(835	)		—			—		(835	)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable		(402,795	)		—			—		(402,795	)
Prepaids and other assets		5,737			(19,197	)		—		(13,460	)
Income tax accounts		2,598			(50	)		—		2,548
Accounts payable		(3,312	)		(1,080	)		—		(4,392	)
Accrued compensation and physician payable		5,095			—			—		5,095
Other accrued liabilities		(17,669	)		18,985			—		1,316
Professional liability reserves		(6,324	)		1,245			—		(5,079	)
Net cash provided by operating activities		16,599			12,626			—		29,225
Investing activities
Purchases of property and equipment		(8,053	)		—			—		(8,053	)
Cash paid for acquisitions, net		(1,094	)		—			—		(1,094	)
Net change in captive investments		—			(9,374	)		—		(9,374	)
Other investing activities		125			—			—		125
Net cash used in investing activities		(9,022	)		(9,374	)		—		(18,396	)
Financing activities
Payments on notes payable		(2,125	)		—			—		(2,125	)
Proceeds from revolving credit facility		69,500			—			—		69,500
Payments on revolving credit facility		(76,300	)		—			—		(76,300	)
Payments of deferred financing costs		(500	)		—			—		(500	)
Redemption of common units		(797	)		—			—		(797	)
Proceeds from sales of common units		50			—			—		50
Net transfers from parent and parent’s subsidiaries		3,252			(3,252	)		—		—
Net cash used in financing activities		(6,920	)		(3,252	)		—		(10,172	)
Net increase in cash		657			—			—		657
Cash and cash equivalents, beginning of period		3,999			—			—		3,999
Cash and cash equivalents, end of period	$	4,656		$	—		$	—	$	4,656

21

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Introduction

We believe we are the largest national provider of outsourced physician staffing and administrative services to hospitals and other healthcare providers in the United States based on revenues and patient visits. Our regional operating models also include comprehensive programs for inpatient care, radiology, pediatrics and other healthcare services, principally within hospital departments and other healthcare treatment facilities. We have, however, focused primarily on providing outsourced services to hospital emergency departments, which accounts for the majority of our revenue.

The following discussion provides an assessment of our results of operations, liquidity and capital resources and should be read in conjunction with our consolidated financial statements and notes thereto included elsewhere in this document.

Critical Accounting Policies and Estimates

The consolidated financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States, which requires us to make estimates and assumptions. Management believes the following critical accounting policies, among others, affect its more significant judgments and estimates used in the preparation of its consolidated financial statements.

There have been no changes to these critical accounting policies or their application during the six months ended June 30, 2008.

Revenue Recognition

Net Revenue. Net revenue consists of fee-for-service revenue, contract revenue and other revenue. Net revenue is recorded in the period services are rendered. Our net revenue is principally derived from the provision of healthcare staffing services to patients within healthcare facilities. The form of billing and related risk of collection for such services may vary by customer. The following is a summary of the principal forms of our billing arrangements and how net revenue is recognized for each.

A significant portion (80% of our net revenue in the six months ended June 30, 2008 and the year ended December 31, 2007) resulted from fee-for-service patient visits. Fee-for-service revenue represents revenue earned under contracts in which we bill and collect the professional component of charges for medical services rendered by our contracted and employed physicians. Under the fee-for-service arrangements, we bill patients for services provided and receive payment from patients or their third-party payers. Fee-for-service revenue is reported net of contractual allowances and policy discounts. All services provided are expected to result in cash flows and are therefore reflected as net revenue in the financial statements. Fee-for-service revenue is recognized in the period that the services are rendered to specific patients and reduced immediately for the estimated impact of contractual allowances in the case of those patients having third-party payer coverage. The recognition of net revenue (gross charges less contractual allowances) from such visits is dependent on such factors as proper completion of medical charts following a patient visit, the forwarding of such charts to one of our billing centers for medical coding and entering into our billing systems and the verification of each patient’s submission or representation at the time services are rendered as to the payer(s) responsible for payment of such services. Net revenue is recorded based on the information known at the time of entering of such information into our billing systems as well as an estimate of the net revenue associated with medical charts for a given service period that have not been processed yet into our billing systems. The above factors and estimates are subject to change. For example, patient payer information may change following an initial attempt to bill for services due to a change in payer status. Such changes in payer status have an impact on recorded net revenue due to differing payers being subject to different contractual allowance amounts. Such changes in net revenue are recognized in the period that such changes in payer become known. Similarly, the actual volume of medical charts not processed into our

22

billing systems may be different from the amounts estimated. Such differences in net revenue are adjusted in the following month based on actual chart volumes processed.

Contract revenue represents revenue generated under contracts in which we provide physician and other healthcare staffing and administrative services in return for a contractually negotiated fee. Contract revenue consists primarily of billings based on hours of healthcare staffing provided at agreed to hourly rates. Revenue in such cases is recognized as the hours are worked by our staff and contractors. Additionally, contract revenue also includes supplemental revenue from hospitals where we may have a fee-for-service contract arrangement. Contract revenue for the supplemental billing in such cases is recognized based on the terms of each individual contract. Such contract terms generally either provide for a fixed monthly dollar amount or a variable amount based upon measurable monthly activity, such as hours staffed, patient visits or collections per visit compared to a minimum activity threshold. Such supplemental revenues based on variable arrangements are usually contractually fixed on a monthly, quarterly or annual calculation basis considering the variable factors negotiated in each such arrangement. Such supplemental revenues are recognized as revenue in the period when such amounts are determined to be fixed and therefore contractually obligated as payable by the customer under the terms of the respective agreement.

Other revenue consists primarily of revenue from management and billing services provided to outside parties. Revenue is recognized for such services pursuant to the terms of the contracts with customers. Generally, such contracts consist of fixed monthly amounts with revenue recognized in the month services are rendered or as hourly consulting fees recognized as revenue as hours are worked in accordance with such arrangements. Additionally, we derive a portion of our revenues from providing billing services that are contingent upon the collection of third-party physician billings by us on their behalf. Such revenues are not considered earned and therefore not recognized as revenue until actual cash collections are achieved in accordance with the contractual arrangements for such services.

Net Revenue Less Provision for Uncollectibles. Net revenue less provision for uncollectibles reflects management’s estimate of billed amounts to ultimately be collected. Management, in estimating the amounts to be collected resulting from its over seven million annual fee-for-service patient visits and procedures, considers such factors as prior contract collection experience, current period changes in payer mix and patient acuity indicators, reimbursement rate trends in governmental and private sector insurance programs, resolution of overprovision account balances, the estimated impact of billing system effectiveness improvement initiatives and trends in collections from self-pay patients and external collection agencies. Such estimates are substantially formulaic in nature. The estimates are continuously updated and adjusted if subsequent actual collection experience indicates a change in estimate is necessary. Such provisions and any subsequent changes in estimates may result in adjustments to our operating results with a corresponding adjustment to our accounts receivable allowance for uncollectibles on our balance sheet.

Accounts Receivable. As described above and below, we determine the estimated value of our accounts receivable based on estimated cash collection run rates of estimated future collections by contract for patient visits under our fee-for-service contract revenue. Accordingly, we are unable to report the payer mix composition on a dollar basis of our outstanding net accounts receivable. Our days revenue outstanding at June 30, 2008 and at December 31, 2007, were 63.0 days and 66.7 days, respectively. The number of days outstanding will fluctuate over time due to a number of factors. The decrease in average days outstanding of approximately 3.7 days includes a decrease of 4.4 days resulting from an increase in average revenue per day and a decrease of 0.7 days associated with the reduction of fee-for-service account receivables. These decreases were partially offset by an increase of 1.4 days related to an increase in the valuation of contract accounts receivable. The increase in average revenue per day is primarily attributable to an increase in gross charges and increased pricing with managed care plans. The decrease of 0.7 days associated with the reduction of fee-for-service accounts receivable and the increase of 1.4 days related to contract accounts receivable are due primarily to timing of cash collections. Our allowance for doubtful accounts totaled $161.1 million as of June 30, 2008.

23

Approximately 98% of our allowance for doubtful accounts is related to gross fees for fee-for-service patient visits. Our principal exposure for uncollectible fee-for-service visits is centered in self-pay patients and, to a lesser extent, for co-payments and deductibles from patients with insurance. While we do not specifically allocate the allowance for doubtful accounts to individual accounts or specific payer classifications, the portion of the allowance associated with fee-for-service charges as of June 30, 2008, was equal to approximately 90% of outstanding self-pay fee-for-service patient accounts.

The majority of our fee-for-service patient visits are for the provision of emergency care in hospital settings. Due to federal government regulations governing the providing of such care, we are obligated to provide emergency care regardless of the patient’s ability to pay or whether or not the patient has insurance or other third-party coverage for the cost of the services rendered. While we attempt to obtain all relevant billing information at the time emergency care services are rendered, there are numerous patient encounters where such information is not available at time of discharge. In such cases where detailed billing information relative to insurance or other third-party coverage is not available at discharge, we attempt to obtain such information from the patient or client hospital billing record information subsequent to discharge to facilitate the collections process. Collections at the time of rendering such services (emergency room discharge) are not significant. Primary responsibility for collection of fee-for-service accounts receivable resides within our internal billing operations. Once a claim has been submitted to a payer or an individual patient, employees within our billing operations have responsibility for the follow up collection efforts. The protocol for follow up differs by payer classification. For self-pay patients, our billing system will automatically send a series of dunning letters on a prescribed time frame requesting payment or the provision of information reflecting that the balance due is covered by another payer, such as Medicare or a third-party insurance plan. Generally, the dunning cycle on a self pay account will run from 90 to 120 days. At the end of this period, if no collections or additional information is obtained from the patient, the account is no longer considered an active account and is transferred to a collection agency. Upon transfer to a collection agency, the patient account is written-off as a bad debt. Any subsequent cash receipts on accounts previously written off are recorded as a recovery. For non-self pay accounts, billing personnel will follow up and respond to any communication from payers such as requests for additional information or denials until collection of the account is obtained or other resolution has occurred. At the completion of our collection cycle, we factor on a non-recourse basis selected patient accounts to external collection agencies and consider the projected value of future factoring proceeds in the estimation of our overall accounts receivable valuation. For contract accounts receivable, invoices for services are prepared in the various operating areas of the Company and mailed to our customers, generally on a monthly basis. Contract terms under such arrangements generally require payment within thirty days of receipt of the invoice. Outstanding invoices are periodically reviewed and operations personnel with responsibility for the customer relationship will contact the customer to follow up on any delinquent invoices. Contract accounts receivable will be considered as bad debt and written-off based upon the individual circumstances of the customer situation after all collection efforts have been exhausted, including legal action if warranted, and it is the judgment of management that the account is not expected to be collected.

Methodology for Computing Allowance for Doubtful Accounts. We employ several methodologies for determining our allowance for doubtful accounts depending on the nature of the net revenue recognized. We initially determine gross revenue for our fee-for-service patient visits based upon established fee schedule prices. Such gross revenue is reduced for estimated contractual allowances for those patient visits covered by contractual insurance arrangements to result in net revenue. Net revenue is then reduced for our estimate of uncollectible amounts. Fee-for-service net revenue less provision for uncollectibles represents our estimated cash to be collected from such patient visits and is net of our estimate of account balances estimated to be uncollectible. The provision for uncollectible fee-for-service patient visits is based on historical experience resulting from over seven million annual patient visits. The significant volume of annual patient visits and the terms of thousands of commercial and managed care contracts and the various reimbursement policies relating to governmental healthcare programs do not make it feasible to evaluate fee-for-service accounts receivable on a specific account basis. Fee-for-service accounts receivable collection estimates are reviewed on a quarterly basis for each of our fee-for-service contracts by period of accounts receivable origination. Such reviews include the use of historical

24

cash collection percentages by contract adjusted for the lapse of time since the date of the patient visit. In addition, when actual collection percentages differ from expected results, on a contract by contract basis, supplemental detailed reviews of the outstanding accounts receivable balances may be performed by our billing operations to determine whether there are facts and circumstances existing that may cause a different conclusion as to the estimate of the collectibility of that contract’s accounts receivable from the estimate resulting from using the historical collection experience. Contract-related net revenue is billed based on the terms of the contract at amounts expected to be collected. Such billings are typically submitted on a monthly basis and aged trial balances prepared. Allowances for estimated uncollectible amounts related to such contract billings are made based upon specific accounts and invoice periodic reviews once it is concluded that such amounts are not likely to be collected. The methodologies employed to compute allowances for doubtful accounts were unchanged between 2008 and 2007.

Insurance Reserves. The nature of our business is such that it is subject to professional liability lawsuits. Historically, to mitigate a portion of this risk, we have maintained insurance for individual professional liability claims with per incident and annual aggregate limits per physician for all incidents. Prior to March 12, 2003, we obtained such insurance coverage from a commercial insurance provider. Professional liability claims and lawsuits are routinely reviewed by our insurance carrier and management for purposes of establishing ultimate loss estimates. Provisions for estimated losses in excess of insurance limits have been provided at the time such determinations are made. In addition, where as a condition of a professional liability insurance policy the policy includes a self-insured risk retention layer of coverage, we have recorded a provision for estimated losses likely to be incurred during such periods and within such limits based on our past loss experience following consultation with our outside insurance experts and claims managers.

Subsequent to March 11, 2003, we have provided for a significant portion of our professional liability loss exposures through the use of a captive insurance company and through greater utilization of self-insurance reserves. Since March 12, 2003, our professional liability costs consist of annual projected costs resulting from periodic actuarial studies along with the cost of certain professional liability commercial insurance premiums and programs available to us and costs incurred in the operation of the insurance program. An independent actuary firm is responsible for preparation of the periodic actuarial studies. Management’s estimate of our professional liability costs resulting from such actuarial studies is significantly influenced by assumptions, which are limited by the uncertainty of predicting future events, and assessments regarding expectations of several factors. These factors include, but are not limited to: hours of exposure as measured by hours of physician and related professional staff services as well as actual loss development trends; the frequency and severity of claims, which can differ significantly by jurisdiction; coverage limits of third-party insurance; the effectiveness of our claims management process; and the outcome of litigation.

Our commercial insurance policy for professional liability losses for the period March 12, 1999 through March 11, 2003, included insured limits applicable to such coverage in the period. Effective April 2006, we executed an agreement with the commercial insurance provider that issued the policy that ended March 11, 2003 to increase the existing $130.0 million aggregate limit of coverage. Under the terms of the agreement, we will make periodic premium payments to the commercial insurance company and the total aggregate limit of coverage under the policy will be increased by a portion of the premiums paid. We have committed to fund premiums such that the total aggregate limit of coverage under the program remains greater than the paid losses at any point in time. During fiscal year 2007, we funded a total of $9.6 million under this agreement. For the six months ended June 30, 2008 we funded a total of $1.5 million under this agreement. We have the option to fund additional payments which will be based upon the level of incurred losses relative to the aggregate limit of coverage at that time. As of June 30, 2008, the current aggregate limit of coverage under this policy is $150.8 million and the estimated loss reserve for claim losses and expenses in excess of the current aggregate limit recorded by the Company was $15.3 million.

Our provisions for losses under the aggregate loss limits of our policy in effect prior to March 12, 2003, and under our captive insurance and self-insurance programs since March 12, 2003, are subject to periodic actuarial

25

re-evaluation. The results of such periodic actuarial studies may result in either upward or downward adjustment to our previous loss estimates. The Company’s estimated loss reserves under such programs are discounted at 3.6%.

The accounts of the captive insurance company are fully consolidated with those of our other operations in the accompanying financial statements.

Impairment of Intangible Assets

In assessing the recoverability of the Company’s intangibles, we must make assumptions regarding estimated future cash flows and other factors to determine the fair value of the respective assets. If these estimates or their related assumptions change in the future, we may be required to record impairment charges for these assets.

Factors and Trends that Affect Our Results of Operations

In reading our financial statements, you should be aware of the following factors and trends that we believe are important in understanding our financial performance.

2008 and 2009 Medicare Fee Schedule Changes

During 2007, the Centers for Medicare & Medicaid Services (“CMS”) initially announced a proposed reduction in the Medicare Conversion Factor (“Conversion Factor”) applicable to all Medicare physician fee payments in the amount of 10.1% for 2008, a reduction required by a statutory formula.

CMS also announced that emergency physicians would see a further reduction of approximately 2.0% resulting from proposed changes in the Practice Expense Relative Value Units (“RVU”) for Evaluation and Management codes associated with emergency physicians. Evaluation and Management services are those which reflect time and effort that physicians spend with patients in assessing their condition and are the primary type of code billed in Emergency Medicine. The initial proposed reduction in 2008 Medicare payments was 12.1% for emergency physicians.

In December 2007, President Bush signed into law the Medicare, Medicaid and SCHIP Extension Acts of 2007. The legislation provided a 0.5% positive update for the 2008 Medicare Physician Fee Schedule for the six month period from January 1, 2008 to June 30, 2008. In July 2008, Congress passed the Medicare Improvement Act for Patients and Providers. The legislation provides a 0.5% increase for the 2008 Medicare Physician Fee Schedule for the period from July 1, 2008 through December 31, 2008 (effectively taking the originally proposed 10.1% reduction to a 0.5% increase). The new legislation also provides for a 1.1% increase in 2009 over the 2008 rates and extends the Physician Quality Reporting Initiative (PQRI) through 2010, increasing the reporting bonus from 1.5% in 2008 to 2.0% in 2009 and 2010. The new legislation did not affect the 2.0% decrease from the changes in the emergency medicine RVU factors.

The total estimated reduction in emergency physician reimbursement rates through December 31, 2008 is 1.5%, which we estimate will negatively affect our revenues from Medicare and other revenue sources whose rates are linked to changes in the Medicare fee schedule by an estimated $1.0 million for the six month period from July 1, 2008 to December 31, 2008.

2008 Coding and Billing Changes

We are subject to various coding and billing criteria related to how certain emergency department physician services can be billed. The way we are able to bill for these services may be modified or changed from time to time eliminating or reducing our reimbursement for these services. The annual negative revenue impact of the

26

changes currently in effect, including the elimination of our capability to bill for intravenous infusion of medications and rehydration treatment services in hospital emergency department settings, is estimated to be approximately $10.0 million during 2008. We are working to counter the adverse impact of the reimbursement reductions currently in effect as well as any future reimbursement reductions through a variety of initiatives, including improved provider productivity, increases in the efficiency and effectiveness of our revenue cycle process, and the reduction or deferral of certain operating costs.

Anesthesiology related services

In January 2007, we completed a strategic review of our anesthesia management services business, and based upon our review concluded that the existing business model of providing management services to independent physician groups was not a viable long term strategy and could not consistently meet our internal growth targets. As a result of this review, we elected to exit this non-core business line. The final phase of this business line disposal was completed in 2007 with no continuing operations in 2008, therefore under the provisions of Statement of Financial Accounting Standards (“SFAS”) No. 144, “Accounting for the Impairment of or Disposal of Long Lived Assets”, we have reported the results of the anesthesia operations as discontinued operations for all applicable periods presented.

Results of Operations

The following discussion provides an analysis of our results of operations and should be read in conjunction with our unaudited consolidated financial statements. The operating results of the periods presented were not significantly affected by general inflation in the U.S. economy. Net revenue less the provision for uncollectibles is an estimate of future cash collections and as such it is a key measurement by which management evaluates performance of individual contracts as well as the Company as a whole. The following table sets forth the components of net earnings as a percentage of net revenue less provision for uncollectibles for the periods indicated:

	Three Months Ended June 30,				Six Months Ended June 30,
	2008		2007		2008		2007
Net revenue less provision for uncollectibles	100.0	%	100.0	%	100.0	%	100.0	%
Professional service expenses	77.1		77.2		77.2		76.5
Professional liability costs	3.7		3.9		1.9		1.0
Gross profit	19.2		18.9		20.9		22.5
General and administrative expenses	9.2		8.9		8.9		9.1
Management fee and other expenses	0.3		0.3		0.3		0.3
Transaction costs	0.5		—		0.3		—
Depreciation and amortization	1.2		1.2		1.2		1.2
Interest expense, net	3.3		4.4		3.5		4.6
Earnings from continuing operations before income taxes	4.7		4.1		6.8		7.3
Provision for income taxes	1.9		1.6		2.7		2.8
Earnings from continuing operations	2.9		2.5		4.1		4.5
Loss from discontinued operations, net of taxes	—		—		—		(0.1	)
Net earnings	2.9	%	2.5	%	4.1	%	4.4	%

27

Three Months Ended June 30, 2008 Compared to the Three Months Ended June 30, 2007

Net Revenue. Net revenue in the three months ended June 30, 2008 increased $60.8 million or 11.7%, to $579.0 million from $518.2 million in the three months ended June 30, 2007. The increase in net revenue of $60.8 million resulted primarily from increases in fee-for-service revenue of $52.1 million and contract revenue of $9.7 million. These increases were slightly offset by a $1.0 million decrease in other revenue. In the three months ended June 30, 2008, fee-for-service revenue was 79.9% of net revenue compared to 79.2% in 2007, contract revenue was 19.2% of net revenue in 2008 compared to 19.5% in 2007 and other revenue was 1.0% in 2008 compared to 1.3% in 2007.

Provision for Uncollectibles. The provision for uncollectibles was $243.5 million in the three months ended June 30, 2008 compared to $215.4 million in the corresponding period in 2007, an increase of $28.1 million or 13.1%. The provision for uncollectibles as a percentage of net revenue was 42.1% in 2008 compared with 41.6% in 2007. The provision for uncollectibles is primarily related to revenue generated under fee-for-service contracts that is not expected to be fully collected. The period over period increase in the provision is due to a combination of increases in the total billed patient volume and annual increases in gross fee schedules. For the three months ended June 30, 2008 self pay fee-for-service visits were approximately 22.1% of the total fee-for-service visits compared to approximately 22.2% in the same period of 2007.

Net Revenue Less Provision for Uncollectibles. Net revenue less provision for uncollectibles in the three months ended June 30, 2008 increased $32.7 million, or 10.8%, to $335.5 million from $302.8 million in the three months ended June 30, 2007. Same contract revenue, which consists of contracts under management in both periods, increased $17.5 million, or 6.3%, to $297.2 million in 2008 compared to $279.6 million in 2007. The increase in same contract revenue of 6.3% consists of increases in patient dollar volume between periods which contributed 1.4% of the growth and increases in contract and other revenue which contributed approximately 2.1% of the growth between periods. Increases in estimated collections per billing unit contributed 1.9% of the growth in same contract revenue as annual increases in gross charges and managed care pricing improvements were offset by reductions in Medicare reimbursements and by reductions in patient acuity between periods primarily as a result of coding changes that became effective during 2008. Changes in prior year revenue estimates increased same contract revenue growth by 0.2% and settlements with managed care plans contributed 0.7% of same contract growth. The remainder of the increase in revenue less provision for uncollectibles between periods is due to new contracts obtained through internal sales of $34.7 million partially offset by $21.0 million of revenue derived from contracts that terminated during the periods. Acquisitions contributed $1.5 million of growth between periods.

Professional Service Expenses. Professional service expenses, which include physician costs, billing and collection expenses, and other professional expenses, totaled $258.6 million in the three months ended June 30, 2008 compared to $233.7 million in the three months ended June 30, 2007, an increase of $24.9 million or 10.6%. The increase of $24.9 million included an increase of approximately $12.7 million which resulted principally from increases in the number of provider hours staffed and the average rates paid per hour of provider service on a same contract basis. Also contributing to the increase in expense was $11.1 million related to new sales net of terminated contracts and $1.0 million related to our acquisitions.

Professional Liability Costs. Professional liability costs were $12.5 million in the three months ended June 30, 2008 compared to $11.9 million in the three months ended June 30, 2007 for an increase of $0.6 million. Costs associated with an increase in provider hours due to net growth and increased provider hours staffed on a same contract basis have been partially offset by a decrease in the actuarial estimate of current period losses under our self insurance program.

Gross Profit. Gross profit was $64.4 million in the three months ended June 30, 2008 compared to $57.2 million in the same period in 2007 for an increase of $7.2 million between periods. Gross profit as a percentage of net revenue less provision for uncollectibles increased to 19.2% in 2008 compared with 18.9% in 2007. The increase in gross profit is primarily due to the contribution from our new contracts and improvements on a same contract basis between periods.

28

General and Administrative Expenses. General and administrative expenses increased $3.8 million to $30.8 million for the three months ended June 30, 2008 from $27.0 million in the three months ended June 30, 2007. General and administrative expenses as a percentage of net revenue less provision for uncollectibles increased to 9.2% in 2008 from 8.9% in 2007. The increase in general and administrative expenses is primarily due to inflationary growth in salaries and increased incentive plan and relocation costs, higher travel costs and an increase in severance costs between periods.

Management Fee and Other Expenses. Management fee and other expenses were $0.9 million in the three months ended June 30, 2008 and 2007.

Depreciation and Amortization. Depreciation and amortization expense was $4.1 million in the three months ended June 30, 2008 compared to $3.6 million for the three months ended June 30, 2007. The increase of $0.5 million between periods was primarily due to higher depreciation expense related to growth in capital expenditures and increased amortization expense associated with acquisitions completed in 2007 and 2008.

Net Interest Expense. Net interest expense decreased $2.4 million to $11.0 million in the three months ended June 30, 2008, compared to $13.3 million in the corresponding period in 2007 primarily due to a lower interest rate environment in 2008.

Transaction Costs. Transaction costs were $1.8 million for the three months ended June 30, 2008. These costs relate to advisory, legal, accounting and other fees incurred related to ongoing acquisition discussions that terminated in June 2008.

Earnings from Continuing Operations before Income Taxes. Earnings from continuing operations before income taxes in the three months ended June 30, 2008 were $15.8 million compared to $12.4 million in the corresponding period in 2007.

Provision for Income Taxes. The provision for income taxes was $6.2 million in the three months ended June 30, 2008 compared to $4.7 million in the corresponding period in 2007.

Earnings from Continuing Operations. Earnings from continuing operations were $9.6 million compared to $7.7 million in the corresponding period in 2007.

Loss from Discontinued Operations, net of taxes. Loss from discontinued operations, net of taxes was $0.1 million for the three months ended June 30, 2007. Contributing to the loss in 2007 were $0.2 million of severance and other exit costs related to the disposal of the anesthesia business unit.

Net Earnings. Net earnings were $9.6 million in the three months ended June 30, 2008 compared to $7.6 million in the three months ended June 30, 2007.

Six Months Ended June 30, 2008 Compared to the Six Months Ended June 30, 2007

Net Revenue. Net revenue in the six months ended June 30, 2008 increased $133.9 million or 13.3%, to $1,138.0 million from $1,004.1 million in the six months ended June 30, 2007. The increase in net revenue of $133.9 million resulted primarily from increases in fee-for-service revenue of $118.5 million and contract revenue of $16.6 million. These increases were slightly offset by a $1.2 million decrease in other revenue. In the six months ended June 30, 2008, fee-for-service revenue was 79.8% of net revenue compared to 78.6% in 2007, contract revenue was 19.2% of net revenue in 2008 compared to 20.1% in 2007 and other revenue was 1.0% in 2008 compared to 1.2% in 2007.

Provision for Uncollectibles. The provision for uncollectibles was $472.5 million in the six months ended June 30, 2008 compared to $400.2 million in the corresponding period in 2007, an increase of $72.3 million or

29

18.1%. The provision for uncollectibles as a percentage of net revenue was 41.5% in 2008 compared with 39.9% in 2007. The provision for uncollectibles is primarily related to revenue generated under fee-for-service contracts that is not expected to be fully collected. The period over period increase in the provision is due to a combination of increases in the total billed patient volume, annual increases in gross fee schedules and an increase in self pay gross accounts receivable relative to other payer types. For the six months ended June 30, 2008 self pay fee-for-service patient visits were approximately 22.0% of total fee-for-service patient visits compared to approximately 21.8% in the same period of 2007.

Net Revenue Less Provision for Uncollectibles. Net revenue less provision for uncollectibles in the six months ended June 30, 2008 increased $61.6 million, or 10.2%, to $665.5 million from $603.9 million in the six months ended June 30, 2007. Same contract revenue, which consists of contracts under management in both periods, increased $35.3 million, or 6.6%, to $572.7 million in 2008 compared to $537.3 million in 2007. The increase in same contract revenue of 6.6% consists primarily of increases in patient dollar volume between periods which contributed 2.4% of the growth and increases in contract revenue which contributed approximately 2.7% of the growth between periods. Increases in estimated collections per billing unit contributed 1.3% of the growth in same contract revenue as annual increases in gross charges and managed care pricing improvements were offset by reductions in Medicare reimbursements and by reductions in patient acuity between periods primarily as a result of coding changes that became effective during 2008 along with an unfavorable shift in payer mix reflecting an increase in the percentage of self pay volume between periods. Also contributing to the increase is an approximately 0.3% increase related to the favorable resolution of a settlement with a managed care plan. Changes in prior year revenue estimates and other accounts receivable valuation assumptions reduced same contract revenue growth by 0.1%. The remainder of the increase in revenue less provision for uncollectibles between periods is due to new contracts obtained through internal sales of $68.5 million partially offset by $44.9 million of revenue derived from contracts that terminated during the periods. Acquisitions contributed $2.6 million of growth between periods.

Professional Service Expenses. Professional service expenses, which include physician costs, billing and collection expenses, and other professional expenses, totaled $513.8 million in the six months ended June 30, 2008 compared to $462.0 million in the six months ended June 30, 2007, an increase of $51.8 million or 11.2%. The increase of $51.8 million included an increase of approximately $27.9 million which resulted principally from increases in the number of provider hours staffed and the increases in average rates paid per hour of provider service on a same contract basis. Also contributing to the increase in expense was $22.3 million related to new sales net of terminated contracts and $1.7 million related to our acquisitions.

Professional Liability Costs. Professional liability costs were $12.6 million in the six months ended June 30, 2008 compared to $6.2 million in the six months ended June 30, 2007 for an increase of $6.3 million. Professional liability costs for the six months ended June 30, 2008 and 2007 include reductions in professional liability reserves relating to prior years of $13.8 million in 2008 and $19.6 million in 2007 resulting from our actuarial studies completed in April of each year. Excluding the favorable actuarial adjustments, professional liability costs increased $0.6 million between periods. Costs associated with an increase in provider hours due to net growth and increased provider hours staffed on a same contract basis have been partially offset by a decrease in the actuarial estimate of current period losses under our self insurance program. The reduction in prior professional liability reserves is due to favorable trends in loss estimates primarily associated with improvements in overall frequency of claims reported and favorable changes in loss development assumptions.

Gross Profit. Gross profit was $139.2 million in the six months ended June 30, 2008 compared to $135.7 million in the same period in 2007 for an increase of $3.5 million between periods. Excluding the impact of the prior year professional liability reserve adjustments in each period, gross profit increased $9.2 million. The increase in gross profit, excluding the actuarial adjustments, is primarily due to improvements on a same contract basis between periods and the contribution from our acquisitions.

30

Gross profit as a percentage of revenue less provision for uncollectibles was 20.9% in 2008 compared with 22.5% in 2007. Excluding the impact of the favorable actuarial adjustments in both periods, gross profit as a percentage of revenue was 18.8% in 2008 compared with 19.2% in 2007.

General and Administrative Expenses. General and administrative expenses increased $4.1 million to $59.0 million for the six months ended June 30, 2008 from $54.8 million in the six months ended June 30, 2007. General and administrative expenses as a percentage of net revenue less provision for uncollectibles declined to 8.9% in 2008 from 9.1% in 2007. The increase in general and administrative expenses is primarily due to inflationary growth in salaries and an increase in the number of employees as well as increased incentive plan costs and higher travel costs.

Management Fee and Other Expenses. Management fee and other expenses were $1.8 million in the six months ended June 30, 2008 and 2007.

Depreciation and Amortization. Depreciation and amortization expense was $8.0 million in the six months ended June 30, 2008 compared to $7.1 million for the six months ended June 30, 2007. The increase of $0.9 million between periods was primarily due to higher depreciation expense related to growth in capital expenditures during 2007.

Net Interest Expense. Net interest expense decreased $4.2 million to $23.6 million in the six months ended June 30, 2008, compared to $27.8 million in the corresponding period in 2007 primarily due to the reduction of our interest rate on the term loan as a result of the second quarter 2007 amendment to our senior credit agreement and a lower interest rate environment in 2008.

Transaction Costs. Transaction costs were $1.8 million for the six months ended June 30, 2008. These costs relate to advisory, legal, accounting and other fees incurred related to ongoing acquisition discussions that terminated in June 2008.

Earnings from Continuing Operations before Income Taxes. Earnings from continuing operations before income taxes in the six months ended June 30, 2008 were $45.0 million compared to $44.2 million in the corresponding period in 2007.

Provision for Income Taxes. The provision for income taxes was $17.9 million in the six months ended June 30, 2008 compared to $17.2 million in the corresponding period in 2007.

Earnings from Continuing Operations. Earnings from continuing operations were $27.1 million compared to $27.0 million in the corresponding period in 2007.

Loss from Discontinued Operations, net of taxes. Loss from discontinued operations, net of taxes was $0.3 million for the six months ended June 30, 2007. Contributing to the loss in 2007 were $0.9 million of severance and other exit costs related to the disposal of the anesthesia business unit.

Net Earnings. Net earnings were $27.1 million in the six months ended June 30, 2008 compared to $26.6 million in the six months ended June 30, 2007.

Liquidity and Capital Resources

Our principal ongoing uses of cash are to meet working capital requirements, fund debt obligations and to finance our capital expenditures and acquisitions. We believe that our cash needs, other than for significant acquisitions, will continue to be met through the use of existing available cash, cash flows derived from future operating results and cash generated from borrowings under our senior secured revolving credit facility.

31

Cash provided by operating activities in the six months ended June 30, 2008 was $32.2 million compared to $29.2 million in the corresponding period in 2007. The $3.0 million increase in cash provided by operating activities was principally due to reduced cash funding for professional liability program costs partially offset by increased claim payments between periods. Cash used in investing activities in the six months ended June 30, 2008 was $22.0 million compared to $18.4 million in the same period of 2007. The $3.6 million increase in cash used in investing activities was principally due to an increase in cash payments made related to acquisitions offset by a decrease in capital expenditures. Cash used in financing activities in the six months ended June 30, 2008 was $3.4 million compared to $10.2 million in the six months ended June 30, 2007. The $6.2 million decrease in cash used in financing activities was principally due to the net reduction in outstanding amounts under the revolving credit facility during 2007.

We spent $4.5 million in the first six months of 2008 and $8.1 million in the first six months of 2007 for capital expenditures. These expenditures were primarily for information technology investments and related development projects along with projects in support of operational initiatives. The $3.6 million decrease between periods is mainly attributable to higher expenditures in the prior period related to certain capital projects completed during 2007.

We are highly leveraged. As of June 30, 2008, we had $629.4 million in aggregate indebtedness, with an additional $125.0 million of borrowing capacity available under our senior secured revolving credit facility (without giving effect to $7.2 million of undrawn letters of credit).

Borrowings outstanding under the senior credit facility mature in various years with a final maturity date of November 23, 2012. The senior credit facility agreement contains both affirmative and negative covenants, including limitations on our ability to incur additional indebtedness, sell material assets, retire, redeem or otherwise reacquire our capital stock, acquire the capital stock or assets of another business, pay dividends, and require the Company to comply with certain coverage and leverage ratios. The senior credit agreement also includes a provision for the prepayment of a portion of the outstanding term loan amounts at any year-end if we generate “excess cash flow”, as defined in the agreement.

During the six months ended June 30, 2008, we entered into three separate forward interest rate swap agreements. The objective of the agreements is to eliminate the variability of the cash flows in interest payments for $200.0 million of the variable-rate term loan for a three year period. The agreements are contracts to exchange, on a quarterly basis, floating interest rate payments based on the Eurocurrency rate, for fixed interest payments over the life of the agreements. We have determined that the interest rate swaps are highly effective and qualify for hedge accounting, therefore at June 30, 2008, we have recorded the increase in fair value of the interest rate swaps, net of tax, of approximately $3.0 million as a component of other comprehensive earnings.

These agreements expose us to credit losses in the event of non-performance by the counterparty to the financial instruments. The counterparty is a creditworthy financial institution and we believe the counterparty will be able to fully satisfy its obligations under the contracts.

Effective April 5, 2007, we amended our senior credit agreement. The amendment reduced the interest rate on any term loans outstanding equal to the euro dollar rate plus 2.00% or the agent bank’s base rate plus 1.00%. Previously, the interest rate on term loan borrowings was equal to the euro dollar rate plus 2.50% or the agent bank’s base rate plus 1.50%. We are subject to an increase in the term loan interest rate in the amount of 0.25% in the event of a downgrade in the corporate family rating of the Company by either Moody’s or Standard and Poor’s rating agencies. Other significant terms and conditions of the credit agreement, including the maturity date of November 23, 2012, did not change under the amendment.

Subject to any contractual restrictions, the Company and its subsidiaries, affiliates or significant shareholders (including The Blackstone Group L.P. and its affiliates) may from time to time, in their sole

32

discretion, purchase, repay, redeem or retire any of the Company’s outstanding debt or equity securities (including any publicly issued debt or equity securities), in privately negotiated or open market transactions, by tender offer or otherwise.

As of June 30, 2008, we had total cash and cash equivalents of approximately $37.1 million. Our ongoing cash needs for the six months ended June 30, 2008 were substantially met from internally generated operating sources. As of June 30, 2008 there were no amounts outstanding under the revolving credit facility.

During the six months ended June 30, 2008, $7.5 million in payments were made related to current year acquisitions and no contingent consideration was paid on prior year acquisitions. For the same period in 2007, $1.1 million in cash payments were made related to contingent considerations paid on a prior year acquisition. Future contingent payment obligations are approximately $18.5 million as of June 30, 2008.

Effective March 12, 2003, we began providing for professional liability risks in part through a captive insurance company. Prior to such date we insured such risks principally through the commercial insurance market. The change in the professional liability insurance program initially resulted in increased cash flow due to the retention of cash formerly paid out in the form of insurance premiums to a commercial insurance company coupled with a long period (typically 2-4 years or longer on average) before cash payout of such losses occurs. A portion of such cash retained is retained within our captive insurance company and therefore not immediately available for general corporate purposes. As of June 30, 2008, the current value of cash or cash equivalents and related investments held within the captive insurance company totaled approximately $86.0 million. Effective June 1, 2008, we have renewed our fronting carrier program with a commercial insurance carrier through May 31, 2009. In connection with this renewal, we paid cash premiums of approximately $10.8 million during the second quarter of 2008. Based upon the results of our most recent actuarial report and insurance program renewal, we anticipate cash funding to the captive insurance subsidiary of approximately $22.3 million. We anticipate such fundings to the captive insurance subsidiary will commence during October 2008 and will continue through May 2009. We also, for the six months ended June 30, 2008, funded a total of $1.5 million to a commercial insurance provider in order to meet our obligation for incurred costs in excess of the aggregate limits of coverage in place on the commercial insurance policy that ended March 11, 2003. We have the option to fund additional premium payments during 2008 and future periods which will be based upon the level of incurred losses relative to the aggregate limit of coverage at that time.

33

Under the indenture governing the senior subordinated notes, our ability to engage in certain activities such as incurring certain additional indebtedness, making certain investments, and paying certain dividends is tied to ratios based on Adjusted EBITDA (which is defined as “EBITDA” in the indenture). Adjusted EBITDA under the indenture is defined as net earnings before interest expense, taxes, depreciation and amortization, as further adjusted to exclude unusual items, non-cash items and the other adjustments shown in the table below. We believe that the disclosure of the calculation of Adjusted EBITDA provides information that is useful to an investor’s understanding of our liquidity and financial flexibility. Adjusted EBITDA is not a measurement of financial performance or liquidity under generally accepted accounting principles. It should not be considered in isolation or as a substitute for net income, operating income, cash flows from operating, investing or financing activities, or any other measure calculated in accordance with generally accepted accounting principles. Adjusted EBITDA as calculated under the indenture for the senior subordinated notes is as follows (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2008		2007		2008		2007
Net earnings	$	9,644	$	7,593	$	27,132	$	26,624
Loss from discontinued operations, net of taxes		—		110		—		346
Interest expense, net		10,953		13,322		23,595		27,792
Provision for income taxes		6,198		4,727		17,900		17,200
Depreciation and amortization		4,125		3,597		8,006		7,087
EBITDA		30,920		29,349		76,633		79,049
Management fee and other expenses(a)		899		885		1,786		1,818
Transaction costs		1,785		—		1,785		—
Restricted unit expense(b)		136		140		276		280
Insurance subsidiary interest income		792		846		1,866		1,486
Severance and other charges		1,075		488		1,459		2,126
Adjusted EBITDA*	$	35,607	$	31,708	$	83,805	$	84,759

 * Adjusted EBITDA totals include the effects of professional liability loss reserve adjustments of $13,835 and $19,599 for the six months ended June 30, 2008 and 2007, respectively. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations”.

(a) Reflects management sponsor fee and loss on disposal of assets.

(b) Reflects costs related to the recognition of expense in connection with the issuance of restricted units under the 2005 unit plan.

Inflation

We do not believe that general inflation in the U.S. economy has had a material impact on our financial position or results of operations.

Seasonality

Historically, our revenues and operating results have reflected minimal seasonal variation due to the significance of revenues derived from patient visits to emergency departments, which are generally open on a 365/366 day basis, and also due to our geographic diversification. Revenue from our non-emergency department staffing lines is dependent on a healthcare facility being open during selected time periods. Revenue in such instances will fluctuate depending upon such factors as the number of holidays in the period.

34

Recently Issued Accounting Standards

In March 2008, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 161, “Disclosures about Derivative Instruments and Hedging Activities—An Amendment of SFAS No. 133” (“SFAS 161”). SFAS 161 seeks to improve financial reporting for derivative instruments and hedging activities by requiring enhanced disclosures regarding the impact on financial position, financial performance, and cash flows. To achieve this increased transparency, SFAS 161 requires (1) the disclosure of the fair value of derivative instruments and gains and losses in a tabular format; (2) the disclosure of derivative features that are credit risk-related; and (3) cross-referencing within the footnotes. SFAS 161 is effective for us on January 1, 2009. We are in the process of evaluating the new disclosure requirements under SFAS 161.

In December 2007, the FASB issued SFAS No. 141 (Revised 2007), “Business Combinations” (“SFAS 141R”). SFAS 141R continues to require the purchase method of accounting to be applied to all business combinations, but it significantly changes the accounting for certain aspects of business combinations. Under SFAS 141R, an acquiring entity will be required to recognize all the assets acquired and liabilities assumed in a transaction at the acquisition-date fair value with limited exceptions. SFAS 141R will change the accounting treatment for certain specific acquisition related items including: (1) expensing acquisition related costs as incurred; (2) valuing noncontrolling interests at fair value at the acquisition date; and (3) recognizing contingent consideration arrangements on the acquisition date at fair value. SFAS 141R also includes a substantial number of new disclosure requirements. SFAS 141R is to be applied prospectively to business combinations for which the acquisition date is on or after January 1, 2009. We expect SFAS 141R will have an impact on our accounting for future business combinations once adopted but the effect is dependent upon the acquisitions that are made in such periods.

In December 2007, the FASB released SFAS No. 160, “Noncontrolling Interests in Consolidated Financial Statements—an amendment of ARB No. 51”. SFAS 160 is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2008, which for the Company is the year ending December 31, 2009 and the interim periods within that fiscal year. The objective of SFAS 160 is to improve the relevance, comparability, and transparency of the financial information that a reporting entity provides in its consolidated financial statements. SFAS 160 currently does not impact the Company as it has full controlling interest of all of its subsidiaries.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities” (“SFAS 159”). SFAS 159 allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (“fair value option”). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, SFAS 159 specifies that unrealized gains and losses for that instrument be reported in earnings at each subsequent reporting date. SFAS 159 was effective for us on January 1, 2008. The implementation of SFAS 159 did not have an impact on our results of operations, financial position or cash flows as we did not elect to measure any eligible items at fair value other than instruments such as investments or interest rate swaps that are currently required to be measured at fair value.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

The Company is exposed to market risk related to changes in interest rates. The Company does not use derivative financial instruments for speculative or trading purposes.

The Company’s earnings are affected by changes in short-term interest rates as a result of its borrowings under its senior credit facilities.

At June 30, 2008, the fair value of the Company’s total debt, which has a carrying value of $629.4 million, was approximately $611.6 million. The Company had $414.4 million of variable debt outstanding at June 30,

35

2008. If the market interest rates for the Company’s variable rate borrowings had averaged 1% more subsequent to December 31, 2007, the Company’s interest expense (excluding the impact of our interest rate swap agreements) would have increased, and earnings before income taxes would have decreased, by approximately $2.1 million for the six months ended June 30, 2008. This analysis does not consider the effects of the reduced level of overall economic activity that could exist in such an environment. Further, in the event of a change of such magnitude, management could take actions in an attempt to further mitigate its exposure to the change. However, due to the uncertainty of the specific actions that would be taken and their possible effects, the sensitivity analysis assumes no changes in the Company’s financial structure. This level of interest rate exposure is consistent with the overall interest rate exposure at December 31, 2007.

Item 4T. Controls and Procedures

The Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer, and Chief Financial Officer of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of June 30, 2008. Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures (1) were effective in timely alerting them to material information relating to the Company (including its consolidated subsidiaries) required to be included in the Company’s periodic SEC filings and (2) were adequate to ensure that information required to be disclosed by the Company in the reports filed or submitted by the Company under the Exchange Act is recorded, processed and summarized and reported within the time periods specified in the SEC’s rules and forms.

During the quarter ended June 30, 2008 there have been no changes in the Company’s internal control over financial reporting identified in connection with the evaluation described above that have materially affected or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

36

PART 2. OTHER INFORMATION

Item 1. Legal Proceedings

We are currently a party to various legal proceedings. While we currently believe that the ultimate outcome of such proceedings, individually and in the aggregate, will not have a material adverse effect on our financial position or overall trends in results of operations, litigation is subject to inherent uncertainties. If an unfavorable ruling were to occur, there exists the possibility of a material adverse impact on our net earnings in the period in which the ruling occurs. The estimate of the potential impact from such legal proceedings on our financial position or overall results of operations could change in the future.

Item 1A. Risk Factors

There are no material changes from the risk factors as previously disclosed in our Form 10-K, filed with the Securities and Exchange Commission on March 11, 2008.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults upon Senior Securities

None.

Item 4. Submission of Matters to a Vote of Security Holders

None.

Item 5. Other Information

None.

37

Item 6. Exhibits

3.1	Certificate of Formation of Team Health Holdings, LLC*
3.2	Amended and Restated Limited Liability Agreement of Team Health Holdings, LLC, dated November 22, 2005*
3.3	Certificate of the Merger of Team Health Holdings LLC and Ensemble Acquisition, LLC, dated November 17, 2005*
3.4	Certificate of Formation of Team Finance LLC*
3.5	Limited Liability Company Agreement of Team Finance LLC*
3.6	Certificate of Incorporation of Health Finance Corporation*
3.7	By-laws of Health Finance Corporation*
4.3	Supplemental indenture dated June 30, 2006.
4.4	Second supplemental indenture dated June 30, 2007.
4.5	Third supplemental indenture dated April 30, 2008.
31.1	Certification by Greg Roth for Team Finance LLC dated August 11, 2008 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification by David P. Jones for Team Finance LLC dated August 11, 2008 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.3	Certification by Greg Roth for Health Finance Corporation dated August 11, 2008 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.4	Certification by David P. Jones for Health Finance Corporation dated August 11, 2008 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification by Greg Roth for Team Finance LLC dated August 11, 2008 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification by David P. Jones for Team Finance LLC dated August 11, 2008 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.3	Certification by Greg Roth for Health Finance Corporation dated August 11, 2008 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.4	Certification by David P. Jones for Health Finance Corporation dated August 11, 2008 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

* Incorporated by reference to the indicated exhibits in the Company’s Registration Statement on Form S-4 dated March 16, 2006.

38

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report on Form 10-Q to be signed on their behalf by the undersigned thereunto duly authorized.

TEAM FINANCE LLC

HEALTH FINANCE CORPORATION

/s/    GREG ROTH        

Greg Roth

Chief Executive Officer

August 11, 2008

/s/    DAVID P. JONES        

David P. Jones

Chief Financial Officer

August 11, 2008

39